Glaxosmithkline | GSK - 资产

金融业

GBP

GBP 82.34B

现金及等价物

GBP 3.3B

GBP 3.47B

GBP 23.59B

GBP 28.82B

GBP 17.75B

股息收益率

GBP 4.47

GBP 2.3B

GBP 4.75B

GBP 69.4K

EPS每股收益

GBP 0.62

股本和储备

GBP 22.06B

GBP 8.75B

债务利息支出

GBP 177.95M

GBP 26M

GBP 19.82B

GBP 105.09B

GBP 846.06M

GBP 9.17B

GBP 2.3B

普通股股本

GBP 4.08B

11.66

GBP 2.46B

GBP 10.09B

销售和管理费用

GBP 3.56B

GBP 6.12B

贸易债权人

GBP 20.72B

应收帐款人

GBP 10.45B

	资产	更改		日
AbbVie	USD 136.46B		2.5B	2026-03
Amgen	USD 92.5B		1.92B	2026-03
AstraZeneca	USD 114.02B		59M	2026-03
Aurora Cannabis	CAD 775.29M		18.43M	2025-12
Bausch Health Companies	USD 24.5B		1.87B	2026-03
Bristol-Myers Squibb	USD 86.48B		3.56B	2026-03
Canopy Growth	CAD 1.11B		36.35M	2025-12
Corcept Therapeutics	USD 814.88M		21.77M	2026-03
Drreddys Laboratories	INR 6.26B		161.9M	2025-12
Eli Lilly	USD 116.58B		4.1B	2026-03
GlaxoSmithKline	GBP 62.87B		1.75B	2026-03
Glaxosmithkline	GBP 82.34B		102.25M	2025-12
J&J	USD 200.89B		1.68B	2026-03
Merck	USD 128.68B		8.18B	2026-03
Novartis	USD 118.53B		7.58B	2026-03
Pacira	USD 1.21B		56.38M	2026-03
Perrigo	USD 7.98B		551.9M	2026-03
Pfizer	USD 207.62B		542M	2026-03
Phibro Animal Health	USD 1.45B		39.56M	2026-03
Prestige Brands	USD 3.49B		52.46M	2025-12
Roche Holding	CHF 100.7B		5.94B	2025-12
Sanofi	EUR 128.02B		1.22B	2026-03
Supernus Pharmaceuticals	USD 1.5B		48.08M	2026-03
Takeda	JPY 15.41T		938.47B	2025-12
Teva Pharmaceutical Industries	USD 40.04B		708M	2026-03
Zoetis	USD 15.15B		313M	2026-03